Probiotix Health PLC - Notice of AGM
Announcement provided by
ProBiotix Health Plc · PBX29/05/2026 07:00
29 May 2026
ProBiotix Health plc
("ProBiotix" or the "Company" or, together with its subsidiary, the "Group")
Notice of Annual General Meeting
ProBiotix Health plc (AQSE: PBX), the life sciences business developing probiotics to support cardiometabolic health, is pleased to announce that Notice convening the Company's Annual General Meeting for 11:00 am on 23 June 2026 at the offices of AlbR Capital Limited, 3rd Floor 80 Cheapside, London EC2V 6EE. The accounts for the year to 31 December 2025, and the Notice of AGM will be available on the Company's website at www.probiotixhealth-ir.com shortly.
For further information, please contact:
|
ProBiotix Health plc |
https://probiotixhealth-ir.com/ |
|
|
investors@probiotixhealth.com |
|
Steen Andersen, Chief Executive Officer Miles Nolan, Investor Relations |
|
|
|
|
|
AlbR Capital Limited Aquis Corporate Adviser and Broker |
|
|
David Coffman Dan Harris
|
Tel: 020 7469 0930 |
|
|
|
Notes to Editors:
ProBiotix is a life sciences company that develops probiotic formulations to support cardiometabolic health. Since its formation, ProBiotix has become recognised as a global leader in microbiome modulating probiotics for use in food supplements and nutraceuticals.
The Company has a unique approach: discovering ground breaking probiotics, ensuring their benefits through robust science, and bringing to market effective finished probiotic-based products for human health across the globe.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
